The Radiotherapy Board also published the ESTRO-HERO report, which estimates the cost of radiotherapy to the NHS for the first time.

The report shows how radiotherapy benefits tens of thousands of patients each year at a relatively modest expense 👇

rcr.ac.uk/news-policy/po…

Yup same operation used for over 40 years. The robot makes ergonomic differences but data suggests its surgeon volume (not the machine) that improves outcomes.

Cf RT for #ProstateCa has been revolutionized.
1990’s: 33+ tx, >50+ BF
2018: 5 tx, 3.5% BF
2028: 2 tx, 🟰BF, ⬆️ QOL?

Nice editorial by Deep Chakrabarti Chris Parker!

🔑 low cost and tox , easy access to prostate RT

🤔 Why we are so focussed on OS benefit in #radonc ? Perhaps we set our bar too high as #radonc treatments are mostly curative?

We need level playing field!

Personalised cancer vaccine trial in melanoma is open ⁦Cambridge University Hospitals NHS ⁦AddenbrookesOncology⁩, led by Dr Corrie⁩! ⁦⁩ Brent O'Carrigan⁩ ⁦NIHR CRN East of England⁩ 👉British man tests first personalised melanoma vaccine ⁦⁦BBC News (UK)⁩ bbc.co.uk/news/health-68…

Missing #BTOG24 ? Don’t worry, we’ve got plenty of key highlights and coverage over at VJOncology.com!

Click here ➡️vjoncology.com/event/btog-2024

BTOG #LungCancer #LCSM #NSCLC #SCLC #Mesothelioma

📢 Calling all breast cancer clinicians in the UK and Internationally! Please participate in our survey on the use of SBRT in oligometastatic breast cancer. Your insights will help shape future clinical trial design!💫

Anna Kirby
#BreastCancer #SBRT
 
forms.office.com/e/DVp7uQYrPj

In car😊Obviously not an exotic place, but rehydrating after a long day at work post #BTOG24 BTOG

BTOG is 20 this year! In our latest 'BTOG Does...' podcast Tom Newsom-Davis
talks to Sanjay Popat about 20 years of BTOG. Listen at btog.org/resources/btog… #btogpodcast

🥰

#BTOG24

That’s it! As our 22nd annual conference closes, we’d like to thank our speakers to sharing their valuable expertise, our hosts, sponsors and all of our amazing attendees. See you here again next year for #BTOG25 ! #BTOG24 #LCSM

Save the dates 3-5 March 2025.

Next up Matthew Hatton gives an overview of providing ontological treatments to patients with ILD and lung cancer 🫁

Our own local experience with radiotherapy and ILD published last year in BJR Journals

❓Is a national database needed?

🔗 academic.oup.com/bjro/article/5…

#BTOG24 BTOG

#HIT -Meso trial (proton beam therapy #radonc ) is coming to a 🇬🇧 cancer centre/unit near you!

Crispin Hiley Asthma + Lung UK

#BTOG24 @btog Stage III NSCLC - Resect or Not? Nice summary by Mariana Brandao #lcsm #radonc

#BTOG24 BTOG #TOURIST #HALT2 trials meeting

Exceptional engagement from 🇬🇧 #radonc colleagues & EORTC University of Zurich Matthias Guckenberger

Matthew Hatton David Woolf Fiona McDonald

Wonderful to listen to Paul van Schil IASLC president, discuss TNMv9. NSCLC: Highlights N2 split into N2a & N2b: by station not node. M1c split to M1c1, M1c2 by organ system.

In Meso cT depends on 3 T measurements and fissure measure. This will be complex to implement! #BTOG24

Matthias Guckenberger updating the UK thoracic oncology community on the role of SABR in bone metastases in NSCLC!

BTOG ESTRO University of Zurich

Day 2 #BTOG24 ⁦BTOG⁩ kicking off! ⁦Fiona McDonald⁩ ⁦Tom Newsom-Davis⁩ ⁦Mary O'Brien⁩ ⁦Matthias Guckenberger⁩ ⁦Sanjay Popat⁩

Nice to see our work received some attention from a special visitor Clive Peedell Hope my trainees had a good conversation and received full marks😉 #BTOG24 BTOG

👇Poster #148

Day 2 #BTOG24 BTOG Grey and overcast outside Visit Belfast!

Do come in for great science and clinical medicine #lcsm #radonc

Elegant (and provocative!) work by Ralph Weichselbaum 🥳 Article title and publication in AACR Clinical Cancer Research really tells what’s in the tin, and should be interpreted as such!